MOLIBRESIB

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C22H22ClN5O2
Molecular Weight	423.895
Optical Activity	UNSPECIFIED
Defined Stereocenters	1 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CCNC(=O)C[C@@H]1N=C(C2=CC=C(Cl)C=C2)C3=CC(OC)=CC=C3N4C(C)=NN=C14

InChI

InChIKey=AAAQFGUYHFJNHI-SFHVURJKSA-N

InChI=1S/C22H22ClN5O2/c1-4-24-20(29)12-18-22-27-26-13(2)28(22)19-10-9-16(30-3)11-17(19)21(25-18)14-5-7-15(23)8-6-14/h5-11,18H,4,12H2,1-3H3,(H,24,29)/t18-/m0/s1

HIDE SMILES / InChI

Molecular Formula	C22H22ClN5O2
Molecular Weight	423.895
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	1 / 1
E/Z Centers	0
Optical Activity	UNSPECIFIED

Approval Year

Substance Class	Chemical Created by `admin` on `Sat Dec 16 01:27:20 UTC 2023` Edited by `admin` on `Sat Dec 16 01:27:20 UTC 2023`
Record UNII	5QIO6SRZ2R
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

MOLIBRESIB

Official Name

English

GSK525762

Code

English

I-BET 762

Code

English

GSK525762A

Code

English

molibresib [INN]

Common Name

English

GSK-525762A

Code

English

GSK-525762

Code

English

MOLIBRESIB [USAN]

Common Name

English

4H-(1,2,4)TRIAZOLO(4,3-A)(1,4)BENZODIAZEPINE-4-ACETAMIDE, 6-(4-CHLOROPHENYL)-N-ETHYL-8-METHOXY-1-METHYL-, (4S)-

Systematic Name

English

BET INHIBITOR GSK525762

Common Name

English

Molibresib [WHO-DD]

Common Name

English

2-((4S)-6-(4-CHLOROPHENYL)-8-METHOXY-1-METHYL-4HBENZO(F)(1,2,4)TRIAZOLO(4,3-A)(1,4)DIAZEPIN-4-YL)-N-ETHYLACETAMIDE

Systematic Name

English

(4S)-6-(4-CHLOROPHENYL)-N-ETHYL-8-METHOXY-1-METHYL-4H-(1,2,4)TRIAZOLO(4,3-A)(1,4)BENZODIAZEPINE-4-ACETAMIDE

Systematic Name

English

Classification Tree Code System Code

NCI_THESAURUS

C128462

Created by admin on Sat Dec 16 01:27:20 UTC 2023 , Edited by admin on Sat Dec 16 01:27:20 UTC 2023

Code System Code Type Description

EPA CompTox

DTXSID60677590

Created by admin on Sat Dec 16 01:27:20 UTC 2023 , Edited by admin on Sat Dec 16 01:27:20 UTC 2023

PRIMARY

USAN

FG-34

Created by admin on Sat Dec 16 01:27:21 UTC 2023 , Edited by admin on Sat Dec 16 01:27:21 UTC 2023

PRIMARY

PUBCHEM

46943432

Created by admin on Sat Dec 16 01:27:20 UTC 2023 , Edited by admin on Sat Dec 16 01:27:20 UTC 2023

PRIMARY

INN

10533

Created by admin on Sat Dec 16 01:27:20 UTC 2023 , Edited by admin on Sat Dec 16 01:27:20 UTC 2023

PRIMARY

FDA UNII

5QIO6SRZ2R

Created by admin on Sat Dec 16 01:27:20 UTC 2023 , Edited by admin on Sat Dec 16 01:27:20 UTC 2023

PRIMARY

SMS_ID

100000175234

Created by admin on Sat Dec 16 01:27:20 UTC 2023 , Edited by admin on Sat Dec 16 01:27:20 UTC 2023

PRIMARY

NCI_THESAURUS

C101538

Created by admin on Sat Dec 16 01:27:20 UTC 2023 , Edited by admin on Sat Dec 16 01:27:20 UTC 2023

PRIMARY

CAS

1260907-17-2

Created by admin on Sat Dec 16 01:27:20 UTC 2023 , Edited by admin on Sat Dec 16 01:27:20 UTC 2023

PRIMARY

Related Record Type Details


					LR4LA8YD5Z

BROMODOMAIN-CONTAINING PROTEIN 2

TARGET -> INHIBITOR

Qualification:

Kd

Amount:


					K04D7I4BCH

MOLIBRESIB BESYLATE

SALT/SOLVATE -> PARENT


					ROBCL9VI3C

BROMODOMAIN-CONTAINING PROTEIN 4

TARGET -> INHIBITOR

Amount:


					7ISX4QDW6N

BROMODOMAIN-CONTAINING PROTEIN 3

TARGET -> INHIBITOR

Qualification:

Kd

Amount:

Related Record Type Details


					5QIO6SRZ2R

MOLIBRESIB

ACTIVE MOIETY